Virtua Health, Inc.
10
3
3
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 70/100
50.0%
5 terminated/withdrawn out of 10 trials
16.7%
-69.8% vs industry average
30%
3 trials in Phase 3/4
500%
5 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
A Prospective Study to Evaluate Robot Assisted Total Knee Replacement Outcomes
Role: lead
The Effect of Pre-Operative Cryoneurolysis on Post-Operative Narcotic Consumption in Patients Undergoing Autograft ACL Reconstruction
Role: lead
Randomized Controlled Trial (RCT) of Open Debridement Versus Tenex
Role: lead
Arista Hemostatic Powder for Total Knee Post Operative Outcomes Study
Role: lead
Evaluate Impact of Exercise Program on Fatigue in Breast Cancer During Chemotherapy
Role: lead
Effectiveness of Smoking Cessation Program in a Community Health System
Role: lead
Colorectal Screening Strategies in Underserved Populations
Role: lead
A Prospective Study to Compare Bupivacaine and Exparel Versus Bupivacaine or Exparel Alone for Postoperative Pain Relief
Role: lead
rhBMP-2 Versus Vivigen in Lumbar Fusion Procedures
Role: lead
A Study to Compare Neostigmine vs Sugammadex in Length of PACU Stay in Patients Undergoing Sleeve Gastrectomy Surgery
Role: lead
All 10 trials loaded